The Energy and Commerce Subcommittee on Health’s meeting on cannabis was a small step forward, but the pot industry can’t succeed without more research.

Cannabis M&A deals continue to crumble due to Department of Justice delays.

With pot stocks still near multiyear lows – and with so much upside on the horizon – 2020 is shaping up to be a year to remember for cannabis.

Justin and Morgan provide their take on what to expect from cannabis M&A in 2020.

A new year is upon us. And in the months ahead, I think we’ll see that cannabis has the wind to its back.

Andy Snyder, founder of Manward Press, is seeking to educate consumers about the potential benefits that hemp-derived CBD can offer.

Now that Canadian shelves are stuffed with all kinds of new cannabis products, what should investors really expect?

Israel is a hotbed for medical marijuana companies and research.

Despite all the positive news, cannabis shares can’t seem to find any footing to begin a new climb higher.

In this episode, we delve into the growing number of legislative efforts to end marijuana prohibition.